Combined Assessment of the Tumor–Stroma Ratio and Tumor Immune Cell Infiltrate for Immune Checkpoint Inhibitor Therapy Response Prediction in Colon Cancer

The best current biomarker strategies for predicting response to immune checkpoint inhibitor (ICI) therapy fail to account for interpatient variability in response rates. The histologic tumor–stroma ratio (TSR) quantifies intratumoral stromal content and was recently found to be predictive of respon...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Cells
المؤلفون الرئيسيون:	Cor J. Ravensbergen, Meaghan Polack, Jessica Roelands, Stijn Crobach, Hein Putter, Hans Gelderblom, Rob A. E. M. Tollenaar, Wilma E. Mesker
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	MDPI AG 2021-10-01
الموضوعات:	tumor–stroma ratio colon cancer tumor-infiltrating immune cells immunotherapy tumor microenvironment checkpoint inhibitor
الوصول للمادة أونلاين:	https://www.mdpi.com/2073-4409/10/11/2935